Ipsos Launches Syndicated MS Patient Community Panel
Ipsos Healthcare, the global healthcare business of Ipsos, announced the launch of its syndicated Multiple Sclerosis (MS) Patient Community Panel.
The Panel will run alongside Ipsos' MS Therapy Monitor and is comprised of MS patients across the US and EU5, with a mix of treatment experiences. Patients will take part in a variety of tasks throughout the year (both syndicated and proprietary), monitored by Ipsos Healthcare's MS experts. This format will allow subscribers to explore key topics throughout the year, while also tapping into the community to answer business questions as they arise.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
